| Literature DB >> 30053297 |
Jason W Adams1, Victor E Alvarez2,3,4, Jesse Mez2,3, Bertrand R Huber2,4, Yorghos Tripodis1,5, Weiming Xia1,6, Gaoyuan Meng1,4,6, Caroline A Kubilus1, Kerry Cormier1, Patrick T Kiernan2, Daniel H Daneshvar1, Alicia S Chua1,5, Sarah Svirsky1, Raymond Nicks1, Bobak Abdolmohammadi1, Laney Evers1, Todd M Solomon1, Jonathan D Cherry2, Nurgul Aytan2, Ian Mahar2, Sherral Devine2,3, Sanford Auerbach2,3, Michael L Alosco2,3, Christopher J Nowinski1,7, Neil W Kowall2,4, Lee E Goldstein1,8, Brigid Dwyer2,9, Douglas I Katz2,9, Robert C Cantu1,7,10,11,12, Robert A Stern2,10,11, Rhoda Au2,3,5,13, Ann C McKee2,3,4,6,8, Thor D Stein1,3,4,6,8.
Abstract
Traumatic brain injury has been associated with increased risk of Parkinson disease and parkinsonism, and parkinsonism and Lewy body disease (LBD) can occur with chronic traumatic encephalopathy (CTE). To test whether contact sports and CTE are associated with LBD, we compared deceased contact sports athletes (n = 269) to cohorts from the community (n = 164) and the Boston University Alzheimer disease (AD) Center (n = 261). Participants with CTE and LBD were more likely to have β-amyloid deposition, dementia, and parkinsonism than CTE alone (p < 0.05). Traditional and hierarchical clustering showed a similar pattern of LBD distribution in CTE compared to LBD alone that was most frequently neocortical, limbic, or brainstem. In the community-based cohort, years of contact sports play were associated with neocortical LBD (OR = 1.30 per year, p = 0.012), and in a pooled analysis a threshold of >8 years of play best predicted neocortical LBD (ROC analysis, OR = 6.24, 95% CI = 1.5-25, p = 0.011), adjusting for age, sex, and APOE ɛ4 allele status. Clinically, dementia was significantly associated with neocortical LBD, CTE stage, and AD; parkinsonism was associated with LBD pathology but not CTE stage. Contact sports participation may increase risk of developing neocortical LBD, and increased LBD frequency may partially explain extrapyramidal motor symptoms sometimes observed in CTE.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30053297 PMCID: PMC6097837 DOI: 10.1093/jnen/nly065
Source DB: PubMed Journal: J Neuropathol Exp Neurol ISSN: 0022-3069 Impact factor: 3.685